Indeed, the pro-thrombotic state notably present during COVID-19, as well as hematological, kidney, hepatic, cardiovascular, neurological and gastrointestinal manifestations extensively reported in COVID-19 [21–47], are largely mediated by abnormalities in the RAAS, ACE2, and TMPRSS2. The gene discussed is TMPRSS2; the disease is COVID-19.